Yahoo! Finance: Top Stories

AbbVie (ABBV) Reports Positive Migraine Drug Results in Phase 3 Trial

Jun 26, 2025 - 10:18
 0
AbbVie (ABBV) Reports Positive Migraine Drug Results in Phase 3 Trial
Read More

Tags:

Previous Article

J&J (JNJ) Faces $8M Verdict Over Talc Case; Stock Still Gains 4.66% YTD

Next Article

Waymo Returns to NYC for Robotaxi Mapping Under Alphabet (GOOGL) Expansion

Related Posts

BofA Names Microsoft (MSFT) a Winner in Small-to-Mid-Size Business Software

BofA Names Microsoft (MSFT) a Winner in Small-to-Mid-Si...

May 31, 2025  0

US planning restrictions on chip design software sales to China

US planning restrictions on chip design software sales ...

May 30, 2025  0

Ecopetrol Will Acquire Ten Renewable Energy Firms from Norway’s Statkraft

Ecopetrol Will Acquire Ten Renewable Energy Firms from ...

May 23, 2025  0